TickerFactsScreenerDevelopers

BridgeBio Pharma, Inc. (BBIO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: $14.89M2017: $85.85M2018: $314.88M2019: $408.45M2020: $57.91M2021: -$870.41M2022: -$1.25B2023: -$1.35B2024: -$1.47B2025: -$2.09B-$2.09B
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$2.09B-42.1%
2024-$1.47B-8.4%
2023-$1.35B-7.9%
2022-$1.25B-44.1%
2021-$870.41M-1603.1%
2020$57.91M-85.8%
2019$408.45M+29.7%
2018$314.88M+266.8%
2017$85.85M+476.6%
2016$14.89M—